Integrated Biopharma Inc
INBP
Revenue
10.30M
▼-2.26M▼-17.99%
3 Months ChangeAssets
26.21M
▼-735.00k▼-2.73%
3 Months ChangeLiabilities
6.97M
▼-1.06M▼-13.22%
3 Months ChangeFree Cash Flow
1.28M
▲333.00k▲35.35%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0001437749-24-029810
2024-05-10
Form 8-K
ID: 0001437749-24-016041
2024-05-10
Form 10-Q
ID: 0001437749-24-016015
2024-02-12
Form 8-K
ID: 0001437749-24-003763
2024-02-12
Form 10-Q
ID: 0001437749-24-003756
2023-11-27
Form 8-K
ID: 0001437749-23-033049
2023-11-09
Form 8-K
ID: 0001437749-23-031188
2023-11-09
Form 10-Q
ID: 0001437749-23-031168
2023-09-15
Form 8-K
ID: 0001437749-23-026058
2023-05-11
Form 8-K
ID: 0001437749-23-013899